23rd Annual · April 2025 · Virtual
2025
- 29 faculty
- 6 recordings
Symposium
Friday, April 25, 2025
- 9:00 AMIntroductory Notes on the 23nd Annual MCI SymposiumRanjan Duara, MD, FAANMt Sinai Medical Center/Wien Center for Alzheimer's Disease and Memory Disorders
9:15 AM - 11:30 PM
- 9:15Session Overview
- 9:20Keynote Machine Learning Methods for Understanding Heterogeneity of Brain Aging
- 9:50Healthy Lifestyle and Cognition in Older Adults with Common Neuropathologies of Dementia
- 10:10
- 10:30A Novel Approach to Model the Genetic and Phenotypic Basis of Exceptional Human Longevity
- 10:50Successful Aging in the 90+ Study
- 11:10Discussion
- 11:30 AMBreak
12:00 PM - 2:20 PM
- 12:00Session Overview
- 12:05Keynote Etiology of White Matter Disease in Autosomal Dominant and Sporadic Alzheimer’s Disease in the DIAN Study
- 12:35White Matter Abnormalities in Autosomal Dominant Alzheimer's Disease: Findings from the Colombia-Boston (COLBOS) Biomarker Study
- 12:55Remembering Dr. Francisco Lopera
- 1:00White Matter Hyperintensities: Can They Be Treated?
- 1:20Cerebral Small Vessel Disease–Related Dementia: More Questions Than Answers
- 1:40Genetic Predisposition for White Matter Hyperintensities and Risk of Mild Cognitive Impairment and Alzheimer’s Disease: Results from the HELIAD Study
- 2:00Discussion
2:20 PM - 4:40 PM
- 2:20Session Overview
- 2:25
- 3:00Effect of Long-Term Maintenance Anti-amyloid Treatment
- 3:20Clinical “Real-World” Experience using Anti-amyloid Therapies
- 3:40
- 4:00Prospects for Dual Anti-amyloid and Anti-tau Treatment for Alzheimer’s Disease
- 4:20Group Discussion
- 4:40Concluding Remarks
- 4:55Symposium ends
Public Forum
Friday, May 2, 2025
- 9:30 AM
9:40 - 11:20
Session 1
SCREENING AND DIAGNOSIS OF ALZHEIMER'S DISEASE
Chair: Mary Ganguli, MD, MPHUniversity of Pittsburgh
- 9:40Session Overview
- 9:45Overview of the Stages of Impairment: Cognitive, Functional, Behavioral Impairment
- 10:05
- 10:25
- 10:45
- 11:05DISCUSSION
11:20 - 12:40
- 11:20Session Overview
- 11:25
- 11:45
- 12:05
- 12:25DISCUSSION
12:40 - 1:40
Session 3
NEW PHARMACOLOGICAL TREATMENTS FOR ALZHEIMER'S DISEASE
Chair: Steven DeKosky, MDUniversity of Florida
- 12:40Session Overview
- 12:45Developments in Anti-amyloid Treatments and Progress with Anti-Tau, GLP1 RA ( “Ozempic”, etc) and Other Agents
- 1:10DISCUSSION
- 1:30Concluding Remarks
- 1:35End
Programs, recordings and slides as published at the time. Slides and recordings appear only where speakers chose to share them. Affiliations are as of 2025.